Xcelience Opens Expanded Tampa, Florida, Headquarters
11/02/2015
The company provides services from preformulation through global clinical supplies packaging and distribution to international pharmaceutical and biotechnology clients for Phases I-IV.
According to the firm, the building houses preformulation and formulation development labs and suites, as well as analytical and stability services, as well as the executive headquarters. Build out plans for a new analytical lab is developing. The company's previous headquarters on West Laurel Street in Tampa is transitioning to provide clinical trial and small-scale commercial manufacturing.
"This year marks a rapid expansion in our service offerings," says Derek Hennecke, President/CEO. "In July we integrated with Powdersize because so many of our clients needed industry-leading micronization services. Now, with this new facility, we will be able to increase capacity throughout the organization. More capacity means we can be more flexible in dealing with changing client needs and timelines."
Project Announcements
NSP Panels Establishes Mullins, South Carolina, Manufacturing Operations
03/25/2026
United Composite Materials Plans Greenville County, South Carolina, Manufacturing Operations
03/25/2026
Van-Am Expands St. Joseph, Missouri, Operations
03/25/2026
Lufburrow & Company Plans Aberdeen, Maryland, Manufacturing Operations
03/24/2026
Autokiniton Expands Bellevue, Ohio, Manufacturing Operations
03/24/2026
Philip Morris International Plans Tampa, Florida, Operations
03/24/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025